Antiparasitic
Medications targeting parasitic infections across diverse classes.
Antiparasitics are a class of medications indicated for the treatment of parasitic diseases, including those caused by helminths, amoeba, ectoparasites, parasitic fungi, and protozoa. They target parasitic agents by destroying them or inhibiting their growth and are usually effective against a limited number of parasites within a particular class. Antiparasitics are one of the antimicrobial drugs, which also include antibiotics and antifungals, and may be administered orally, intravenously, or topically.
- field
- Pharmacology, Infectious Disease
- known_for
- Treatment of parasitic diseases affecting an estimated 2 billion people
- types
- Broad-spectrum, Antiprotozoals, Antihelminthics, Antiamoebics, Antifungals
- administration_routes
- Oral, intravenous, topical
- resistance_concern
- Growing concern, especially in veterinary medicine
Lore & Background
Antiparasitics treat parasitic diseases that impact an estimated 2 billion people. They include broad-spectrum agents like nitazoxanide, as well as specific antiprotozoals (e.g., melarsoprol for sleeping sickness, metronidazole for vaginitis), antihelminthics (e.g., mebendazole for nematodes, praziquantel for tapeworms), antiamoebics (e.g., rifampin, amphotericin B), and antifungals (e.g., fumagillin for microsporidiosis). Overuse or misuse can lead to antimicrobial resistance, and the Egg hatch assay is used to detect resistance in parasites.
Reader's Guide
Antiparasitics are significant because they address a major global health burden, with parasitic diseases affecting an estimated 2 billion people. Resistance, especially in veterinary medicine, remains a growing concern. Research into alternatives such as triazolopyrimidines and their metal complexes aims to reduce side effects and combat drug resistance.
Did You Know?
- Antiparasitics are one of the antimicrobial drugs, which also include antibiotics and antifungals.
- The Egg hatch assay can determine whether a parasite has become resistant to standard drug treatments.
- Metal-containing compounds are being investigated as a new avenue for antiparasitic development.
More in Respiratory & Infectious Diseases 1-24
Elsewhere in the Respiratory & Infectious Diseases universe
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record